Therefore, the aim of this study was to evaluate the association between metabolic syndrome and breast cancer risk in a large-scale sample of Chinese women at large scale and to research whether adiponectin could link metabolic syndrome and breast cancer as a potential molecular mechanism, to provide new insight into the prevention of the disease. Here, ADIPOQ is linked to metabolic syndrome.